Sanofi (SNYN) — Capital Reinvestment Ratio
Sanofi (SNYN) has a Capital Reinvestment Ratio of 0.33x as of December 2025, meaning it reinvests 0% of its operating cash flow (MX$10.75 Billion) in capital expenditures (MX$3.54 Billion). Check SNYN goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sanofi Capital Reinvestment Ratio (2013–2025)
This chart tracks Sanofi's Capital Reinvestment Ratio across 13 annual periods. For the full cash flow conversion analysis, see Sanofi cash conversion from operations.
Annual Capital Reinvestment Ratio for Sanofi (2013–2025)
Year-by-year Capital Reinvestment Ratio for Sanofi from 2013 to 2025. See SNYN free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (MXN) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.33x | MX$10.75 Billion | MX$3.54 Billion | ▼ -6.5% |
| 2024 | 0.35x | MX$9.08 Billion | MX$3.19 Billion | ▲ +19.3% |
| 2023 | 0.29x | MX$10.26 Billion | MX$3.02 Billion | ▲ +93.2% |
| 2022 | 0.15x | MX$10.53 Billion | MX$1.61 Billion | ▲ +8.5% |
| 2021 | 0.14x | MX$10.52 Billion | MX$1.48 Billion | ▼ -16.9% |
| 2020 | 0.17x | MX$7.42 Billion | MX$1.25 Billion | ▼ -1.4% |
| 2019 | 0.17x | MX$7.71 Billion | MX$1.32 Billion | ▼ -32.8% |
| 2018 | 0.26x | MX$5.55 Billion | MX$1.42 Billion | ▲ +35.6% |
| 2017 | 0.19x | MX$7.38 Billion | MX$1.39 Billion | ▼ -29.2% |
| 2016 | 0.27x | MX$7.84 Billion | MX$2.08 Billion | ▲ +97.1% |
| 2015 | 0.13x | MX$8.92 Billion | MX$1.20 Billion | ▼ -28.6% |
| 2014 | 0.19x | MX$7.69 Billion | MX$1.45 Billion | ▲ +0.6% |
| 2013 | 0.19x | MX$6.95 Billion | MX$1.31 Billion | — |